{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:45:47Z","timestamp":1757313947207,"version":"3.37.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biotechnol Lett"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s10529-023-03380-0","type":"journal-article","created":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T09:02:17Z","timestamp":1683363737000},"page":"779-797","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Multi-pathogen based chimeric vaccine to fight against COVID-19 and concomitant coinfections"],"prefix":"10.1007","volume":"45","author":[{"given":"Rupal","family":"Ojha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya K.","family":"Padhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6510-0596","authenticated-orcid":false,"given":"Vijay Kumar","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,6]]},"reference":[{"key":"3380_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ et al (2015) GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1:19\u201325","journal-title":"SoftwareX"},{"issue":"1","key":"3380_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003057","volume":"9","author":"AA Bosch","year":"2013","unstructured":"Bosch AA, Biesbroek G, Trzcinski K, Sanders EA, Bogaert D (2013) Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog 9(1):e1003057","journal-title":"PLoS Pathog"},{"key":"3380_CR3","doi-asserted-by":"publisher","first-page":"7777","DOI":"10.1007\/s00253-020-10814-6","volume":"104","author":"X Chen","year":"2020","unstructured":"Chen X, Liao B, Cheng L, Peng X, Xu X, Li Y, Hu T, Li J, Zhou X, Ren B (2020) The microbial coinfection in COVID-19. Appl Microbiol Biotechnol 104:7777\u20137785","journal-title":"Appl Microbiol Biotechnol"},{"issue":"10","key":"3380_CR4","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1002\/jmv.25987","volume":"92","author":"A Choudhury","year":"2020","unstructured":"Choudhury A, Mukherjee S (2020) In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. J Med Virol 92(10):2105\u20132113","journal-title":"J Med Virol"},{"issue":"5","key":"3380_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s10989-022-10456-4","volume":"28","author":"P Chouhan","year":"2022","unstructured":"Chouhan P, Singh S, Sharma V, Prajapati VK (2022) Anti-IL-10 antibody humanization by SDR grafting with enhanced affinity to neutralize the adverse response of interleukin-10. Int J Pept Res Ther 28(5):148","journal-title":"Int J Pept Res Ther"},{"key":"3380_CR6","unstructured":"ClinicalTrials.gov (2022). ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world."},{"issue":"1","key":"3380_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41541-018-0057-5","volume":"3","author":"RN Coler","year":"2018","unstructured":"Coler RN, Day TA, Ellis R, Piazza FM, Beckmann AM, Vergara J, Rolf T, Lu L, Alter G, Hokey D, Jayashankar L (2018) The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial. Npj Vaccines 3(1):34","journal-title":"Npj Vaccines"},{"key":"3380_CR8","doi-asserted-by":"crossref","unstructured":"Dimitrov, I., I. Bangov, D. R. Flower and I. Doytchinova (2014). AllerTOP v 2\u2014a server for in silico prediction of allergens. Journal of molecular modeling, 20(6): 1\u20136.","DOI":"10.1007\/s00894-014-2278-5"},{"issue":"1","key":"3380_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova IA, Flower DR (2007) VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics 8(1):1\u20137","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"3380_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1600-065X.2010.00978.x","volume":"239","author":"MS Duthie","year":"2011","unstructured":"Duthie MS, Windish HP, Fox CB, Reed SG (2011) Use of defined TLR ligands as adjuvants within human vaccines. Immunol Rev 239(1):178\u2013196","journal-title":"Immunol Rev"},{"issue":"13","key":"3380_CR11","doi-asserted-by":"publisher","first-page":"e00647","DOI":"10.1128\/JVI.00647-20","volume":"94","author":"NK Dutta","year":"2020","unstructured":"Dutta NK, Mazumdar K, Gordy JT (2020) The nucleocapsid protein of SARS\u2013CoV-2: a target for vaccine development. J Virol 94(13):e00647-e720","journal-title":"J Virol"},{"key":"3380_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41479-021-00083-w","volume":"13","author":"C Feldman","year":"2021","unstructured":"Feldman C, Anderson R (2021) The role of co-infections and secondary infections in patients with COVID-19. Pneumonia 13:1\u201315","journal-title":"Pneumonia"},{"issue":"11","key":"3380_CR13","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1164\/rccm.202002-0445OC","volume":"201","author":"Y Feng","year":"2020","unstructured":"Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J, Xiong W, Yang D, Chen R, Lu F, Lu Y, Liu X, Chen Y, Li X, Li Y, Summah HD, Lin H, Yan J, Zhou M, Lu H, Qu J (2020) COVID-19 with different severities: a multicenter study of clinical features. Am J Respir Crit Care Med 201(11):1380\u20131388","journal-title":"Am J Respir Crit Care Med"},{"key":"3380_CR14","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fimmu.2017.00278","volume":"8","author":"W Fleri","year":"2017","unstructured":"Fleri W, Paul S, Dhanda SK, Mahajan S, Xu X, Peters B, Sette A (2017) The immune epitope database and analysis resource in epitope discovery and synthetic vaccine design. Front Immunol 8:278","journal-title":"Front Immunol"},{"issue":"5","key":"3380_CR15","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1086\/527396","volume":"46","author":"A Forsgren","year":"2008","unstructured":"Forsgren A, Riesbeck K (2008) Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines. Clin Infect Diseases 46(5):726\u2013731","journal-title":"Clin Infect Diseases"},{"key":"3380_CR16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1385\/1-59259-890-0:571","volume-title":"The Proteomics Protocols Handbook","author":"E Gasteiger","year":"2005","unstructured":"Gasteiger E, Hoogland C, Gattiker A, Duvaud SE, Wilkins MR, Appel RD, Bairoch A (2005) Protein identification and analysis tools on the ExPASy server. In: Walker JM (ed) The Proteomics Protocols Handbook. Humana press, Totowa, pp 571\u2013607"},{"key":"3380_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ijbiomac.2020.02.297","volume":"152","author":"N Gupta","year":"2020","unstructured":"Gupta N, Regar H, Verma VK, Prusty D, Mishra A, Prajapati VK (2020) Receptor-ligand based molecular interaction to discover adjuvant for immune cell TLRs to develop next-generation vaccine. Int J Biol Macromol 152:535\u2013545","journal-title":"Int J Biol Macromol"},{"issue":"9","key":"3380_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073957","volume":"8","author":"Gupta, S., Kapoor, P., Chaudhary, K., Gautam, A., Kumar, R., Open Source Drug Discovery Consortium and Raghava, G.P","year":"2013","unstructured":"Gupta, S., Kapoor, P., Chaudhary, K., Gautam, A., Kumar, R., Open Source Drug Discovery Consortium and Raghava, G.P (2013) In silico approach for predicting toxicity of peptides and proteins. PLoS ONE 8(9):e73957","journal-title":"PLoS ONE"},{"key":"3380_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.meegid.2019.03.003","volume":"70","author":"M Hasan","year":"2019","unstructured":"Hasan M, Azim KF, Begum A, Khan NA, Shammi TS, Imran AS, Chowdhury IM, Urme SRA (2019) Vaccinomics strategy for developing a unique multi-epitope monovalent vaccine against Marburg marburgvirus. Infect Genet Evol 70:140\u2013157","journal-title":"Infect Genet Evol"},{"issue":"11","key":"3380_CR20","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1110\/ps.062405906","volume":"15","author":"P Haste Andersen","year":"2006","unstructured":"Haste Andersen P, Nielsen M, Lund OLE (2006) Prediction of residues in discontinuous B-cell epitopes using protein 3D structures. Protein Sci 15(11):2558\u20132567","journal-title":"Protein Sci"},{"key":"3380_CR21","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.3389\/fmicb.2019.03154","volume":"10","author":"M Hatherill","year":"2020","unstructured":"Hatherill M, White RG, Hawn TR (2020) Clinical development of new TB vaccines: recent advances and next steps. Front Microbiol 10:3154","journal-title":"Front Microbiol"},{"issue":"3","key":"3380_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"B Hu","year":"2021","unstructured":"Hu B, Guo H, Zhou P, Shi ZL (2021) Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 19(3):141\u2013154","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"3380_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, Beglov D, Vajda S (2017) The ClusPro web server for protein\u2013protein docking. Nat Protoc 12(2):255\u2013278","journal-title":"Nat Protoc"},{"issue":"3","key":"3380_CR24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jmii.2020.02.012","volume":"53","author":"CC Lai","year":"2020","unstructured":"Lai CC, Liu YH, Wang CY, Wang YH, Hsueh SC, Yen MY, Ko WC, Hsueh PR (2020a) Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. J Microbiol Immunol Infect 53(3):404\u2013412","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"3380_CR25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jmii.2020.05.013","volume":"53","author":"CC Lai","year":"2020","unstructured":"Lai CC, Wang CY, Hsueh PR (2020b) Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect 53(4):505\u2013512","journal-title":"J Microbiol Immunol Infect"},{"key":"3380_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-8-424","volume":"8","author":"MV Larsen","year":"2007","unstructured":"Larsen MV, Lundegaard C, Lamberth K, Buus S, Lund O, Nielsen M (2007) Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics 8:1\u201312","journal-title":"BMC Bioinformatics"},{"issue":"8","key":"3380_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104351","volume":"9","author":"SJ Lee","year":"2014","unstructured":"Lee SJ, Shin SJ, Lee MH, Lee MG, Kang TH, Park WS, Soh BY, Park JH, Shin YK, Kim HW, Yun CH (2014) A potential protein adjuvant derived from Mycobacterium tuberculosis Rv0652 enhances dendritic cells-based tumor immunotherapy. PLoS ONE 9(8):e104351","journal-title":"PLoS ONE"},{"issue":"11","key":"3380_CR28","doi-asserted-by":"publisher","first-page":"5499","DOI":"10.4049\/jimmunol.168.11.5499","volume":"168","author":"B Livingston","year":"2002","unstructured":"Livingston B, Crimi C, Newman M, Higashimoto Y, Appella E, Sidney J, Sette A (2002) A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes. J Immunol 168(11):5499\u20135506","journal-title":"J Immunol"},{"issue":"3","key":"3380_CR29","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/prot.10286","volume":"50","author":"SC Lovell","year":"2003","unstructured":"Lovell SC, Davis IW, Arendall WB III, De Bakker PI, Word JM, Prisant MG, Richardson JS, Richardson DC (2003) Structure validation by C\u03b1 geometry: \u03d5, \u03c8 and C\u03b2 deviation. Proteins 50(3):437\u2013450","journal-title":"Proteins"},{"key":"3380_CR30","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.3389\/fmicb.2020.02079","volume":"11","author":"BW Massey","year":"2020","unstructured":"Massey BW, Jayathilake K, Meltzer HY (2020) Respiratory microbial co-infection with SARS-CoV-2. Front Microbiol 11:2079","journal-title":"Front Microbiol"},{"key":"3380_CR31","unstructured":"McGill-University (2022). \"VIPER Group COVID-19 Vaccine Tracker Team.\""},{"issue":"1","key":"3380_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijtb.2020.08.004","volume":"68","author":"PR Mohapatra","year":"2021","unstructured":"Mohapatra PR, Mishra B, Behera B (2021) BCG vaccination induced protection from COVID-19. Indian J Tuberculosis 68(1):119\u2013124","journal-title":"Indian J Tuberculosis"},{"key":"3380_CR33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ijbiomac.2020.04.097","volume":"156","author":"R Ojha","year":"2020","unstructured":"Ojha R, Pandey RK, Prajapati VK (2020) Vaccinomics strategy to concoct a promising subunit vaccine for visceral leishmaniasis targeting sandfly and leishmania antigens. Int J Biol Macromol 156:548\u2013557","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"3380_CR34","doi-asserted-by":"publisher","first-page":"13069","DOI":"10.1021\/acsomega.9b00944","volume":"4","author":"R Ojha","year":"2019","unstructured":"Ojha R, Pareek A, Pandey RK, Prusty D, Prajapati VK (2019) Strategic development of a next-generation multi-epitope vaccine to prevent Nipah virus zoonotic infection. ACS Omega 4(8):13069\u201313079","journal-title":"ACS Omega"},{"issue":"1","key":"3380_CR35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/21645515.2015.1052198","volume":"12","author":"ME Pichichero","year":"2016","unstructured":"Pichichero ME, Khan MN, Xu Q (2016) Next generation protein based Streptococcus pneumoniae vaccines. Hum Vaccin Immunother 12(1):194\u2013205","journal-title":"Hum Vaccin Immunother"},{"issue":"19","key":"3380_CR36","doi-asserted-by":"publisher","first-page":"9096","DOI":"10.1080\/07391102.2021.1924265","volume":"40","author":"VS Rajput","year":"2022","unstructured":"Rajput VS, Sharma R, Kumari A, Vyas N, Prajapati V, Grover A (2022) Engineering a multi epitope vaccine against SARS-CoV-2 by exploiting its non structural and structural proteins. J Biomol Struct Dyn 40(19):9096\u20139113","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"3380_CR37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/prot.21078","volume":"65","author":"S Saha","year":"2006","unstructured":"Saha S, Raghava GPS (2006) Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins 65(1):40\u201348","journal-title":"Proteins"},{"key":"3380_CR38","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/B978-0-323-90264-9.00029-5","volume-title":"Advances in Protein Molecular and Structural Biology Methods","author":"V Sharma","year":"2022","unstructured":"Sharma V, Singh S, Ratnakar TS, Prajapati VK (2022) Chapter 29 - Immunoinformatics and reverse vaccinology methods to design peptide-based vaccines. In: Tripathi T, Dubey VK (eds) Advances in Protein Molecular and Structural Biology Methods. Academic Press, Cambridge, pp 477\u2013487"},{"issue":"2","key":"3380_CR39","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1128\/iai.19.2.391-394.1978","volume":"19","author":"CC Shepard","year":"1978","unstructured":"Shepard CC, Walker LL, Van Landingham RM (1978) Immunity to Mycobacterium leprae infections induced in mice by BCG vaccination at different times before or after challenge. Infect Immun 19(2):391\u2013394","journal-title":"Infect Immun"},{"issue":"1","key":"3380_CR40","doi-asserted-by":"publisher","first-page":"16219","DOI":"10.1038\/s41598-020-73371-y","volume":"10","author":"A Singh","year":"2020","unstructured":"Singh A, Thakur M, Sharma LK, Chandra K (2020) Designing a multi-epitope peptide based vaccine against SARS-CoV-2. Sci Rep 10(1):16219","journal-title":"Sci Rep"},{"issue":"3","key":"3380_CR41","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1086\/649782","volume":"201","author":"B Singh","year":"2010","unstructured":"Singh B, Brant M, Kilian M, Hallstr\u00f6m B, Riesbeck K (2010) Protein E of Haemophilus influenzae is a ubiquitous highly conserved adhesin. J Infect Dis 201(3):414\u2013419","journal-title":"J Infect Dis"},{"key":"3380_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-022-10452-2","author":"S Singh","year":"2022","unstructured":"Singh S, Kumar K, Panda M, Srivastava A, Mishra A, Prajapati VK (2022) High-throughput virtual screening of small-molecule inhibitors targeting immune cell checkpoints to discover new immunotherapeutics for human diseases. Mol Div. https:\/\/doi.org\/10.1007\/s11030-022-10452-2","journal-title":"Mol Div"},{"issue":"9","key":"3380_CR43","first-page":"235","volume":"12","author":"S Singh","year":"2022","unstructured":"Singh S, Prajapati VK (2022) Exploring actinomycetes natural products to identify potential multi-target inhibitors against Leishmania donovani. Biotech 12(9):235","journal-title":"Biotech"},{"issue":"51","key":"3380_CR44","doi-asserted-by":"publisher","first-page":"19874","DOI":"10.1074\/jbc.RA118.002768","volume":"293","author":"A Tandon","year":"2018","unstructured":"Tandon A, Pathak M, Harioudh MK, Ahmad S, Sayeed M, Afshan T, Siddiqi MI, Mitra K, Bhattacharya SM, Ghosh JK (2018) A TLR4-derived non-cytotoxic, self-assembling peptide functions as a vaccine adjuvant in mice. J Biol Chem 293(51):19874\u201319885","journal-title":"J Biol Chem"},{"issue":"4","key":"3380_CR45","doi-asserted-by":"publisher","first-page":"e01806","DOI":"10.1128\/mBio.01806-20","volume":"11","author":"M Vaillancourt","year":"2020","unstructured":"Vaillancourt M, Jorth P (2020) The unrecognized threat of secondary bacterial infections with COVID-19. Mbio 11(4):e01806-e1820","journal-title":"Mbio"},{"issue":"6","key":"3380_CR46","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/infdis\/jiv127","volume":"212","author":"S Vejbaesya","year":"2015","unstructured":"Vejbaesya S, Thongpradit R, Kalayanarooj S, Luangtrakool K, Luangtrakool P, Gibbons RV, Srinak D, Ngammthaworn S, Apisawes K, Yoon IK, Thomas SJ (2015) HLA class I supertype associations with clinical outcome of secondary dengue virus infections in ethnic Thais. J Infect Dis 212(6):939\u2013947","journal-title":"J Infect Dis"},{"key":"3380_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-11-568","volume":"11","author":"P Wang","year":"2010","unstructured":"Wang P, Sidney J, Kim Y, Sette A, Lund O, Nielsen M, Peters B (2010) Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinformatics 11:1\u201312","journal-title":"BMC Bioinformatics"},{"key":"3380_CR48","unstructured":"WHO (2022). \"WHO recommendation Serum Institute of India Pvt. Ltd. (SIIPL) \u2013 COVID-19 vaccine (SARS-CoV-2 rS Protein Nanoparticle [Recombinant]) - COVOVAX\u2122.\""},{"issue":"17\u201318","key":"3380_CR49","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1016\/j.vaccine.2005.01.031","volume":"23","author":"A Yano","year":"2005","unstructured":"Yano A, Onozuka A, Asahi-Ozaki Y, Imai S, Hanada N, Miwa Y, Nisizawa T (2005) An ingenious design for peptide vaccines. Vaccine 23(17\u201318):2322\u20132326","journal-title":"Vaccine"},{"issue":"7","key":"3380_CR50","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41422-021-00495-9","volume":"31","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Kuang M, Li J, Zhu L, Jia Z, Guo X, Hu Y, Kong J, Yin H, Wang X, You F (2021) SARS-CoV-2 spike protein interacts with and activates TLR41. Cell Res 31(7):818\u2013820","journal-title":"Cell Res"},{"issue":"10229","key":"3380_CR51","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 395(10229):1054\u20131062","journal-title":"The Lancet"},{"key":"3380_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2020.198005","volume":"285","author":"X Zhu","year":"2020","unstructured":"Zhu X, Ge Y, Wu T, Zhao K, Chen Y, Wu B, Zhu F, Zhu B, Cui L (2020) Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res 285:198005","journal-title":"Virus Res"}],"container-title":["Biotechnology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-023-03380-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10529-023-03380-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-023-03380-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T05:02:23Z","timestamp":1686891743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10529-023-03380-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,6]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["3380"],"URL":"https:\/\/doi.org\/10.1007\/s10529-023-03380-0","relation":{},"ISSN":["0141-5492","1573-6776"],"issn-type":[{"type":"print","value":"0141-5492"},{"type":"electronic","value":"1573-6776"}],"subject":[],"published":{"date-parts":[[2023,5,6]]},"assertion":[{"value":"10 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}